本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioVie Inc

8.05
-0.4200-4.96%
盘后8.400.3500+4.35%19:54 EDT
成交量:9.45万
成交额:78.57万
市值:1,492.66万
市盈率:-0.48
高:8.59
开:8.40
低:8.04
收:8.47
数据加载中...
2020/11/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/23

重要事件披露

8-K - Current report
2020/09/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/08/07

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/08/06

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/07/15

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/22

重要事件披露

8-K - Current report
2020/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/03/11

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/02/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/11/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2019/11/19

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/11/15

重要事件披露

8-K - Current report
2019/11/07

SEC问询函

CORRESP [Cover] - Correspondence
2019/11/07

SEC问询函

CORRESP [Cover] - Correspondence
2019/11/05

SEC问询函

CORRESP [Cover] - Correspondence